Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity.
about
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 yearsDyslipoproteinaemia in a subset of patients with rheumatoid arthritis.Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients.Antibody deficiency associated with gold treatment: natural history and management in 22 patientsCross-cultural validation of the Educational Needs Assessment Tool in RA in 7 European countries.Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study.Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.Formal education and back pain: a reviewCardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care.Epstein-Barr virus and rheumatoid arthritis: is there a link?Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.Dyslipidaemia in rheumatological autoimmune diseasesImmunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?Increased prevalence of the metabolic syndrome in patients with psoriatic arthritisIntestinal permeability and inflammation in patients on NSAIDs.Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis.No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset.Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.Predictors of diastolic dysfunction in rheumatoid arthritisUtility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritisMethotrexate increases expression of cell cycle checkpoint genes via JNK activationUnmet needs in rheumatoid arthritis.Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritisA Prospective Study Investigating Prediagnostic Leukocyte Telomere Length and Risk of Developing Rheumatoid Arthritis in WomenAtherogenic lipid profiles and its management in patients with rheumatoid arthritis.Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s.Biologic treatments for systemic rheumatic diseasesDrugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.Synovial fluid proteome in rheumatoid arthritis.Hormonal contraception and the development of autoimmunity: A review of the literature.Identification of dysregulated genes in rheumatoid arthritis based on bioinformatics analysis.Capturing real-life patient care in psoriatic arthritis and its risks: the challenge of analysing registry data.
P2860
Q24674079-9817AE1C-2655-414E-BB50-C74158C9B17EQ33566590-C3428BF2-84FD-4B92-981E-BF7D95B8DF6AQ33578306-99438D2C-451B-4F9A-9B60-5C830340D133Q33579212-1D263A0C-E100-4B0F-BF2D-FF808899E9E9Q33910506-44AF0ED9-87BD-44B9-B38F-B3FCF6477858Q34076916-A256D91A-3DF6-4701-8607-FFFDE9ACB191Q34104339-D51072A6-100C-4CED-AD8A-D9D0344F7F3CQ34150320-1728536B-EFCA-4A7D-AF66-0502372657D0Q34286316-4D95D76E-D652-42D2-BA10-DDF041D24F53Q34385631-6530F23D-0563-4550-AA97-5D3D0929D623Q34896078-051FCC05-4330-41FD-9FA4-AB6969D03B57Q35025293-BE84322D-F76D-46CC-AD95-6F1921E605DCQ35029916-28EFCD1C-6DFD-4E28-B2C2-A415E5EE07FEQ35059538-68A5516C-3514-43DB-96D7-E34C942E2272Q35086458-EE85F215-8890-49CF-A199-7174971291F9Q35352791-A799D844-4DDF-49FF-8332-2D3E52D60C44Q35548697-61E78100-72A3-4172-930C-77302225E306Q35549071-172E5ADD-D4BD-440F-8A58-E7187B4BE275Q35605663-1B99CAD0-A96D-40E9-BBE1-005E27C5197EQ35620858-90E1A946-1D80-48D1-B57B-92EFD673CAE5Q35630128-C6E7CF5D-B739-4D37-A9FA-454A284BB425Q35848427-2FDCDB11-FEB9-405B-B414-E2DB785F33D1Q36165321-75E29617-7745-48A0-920C-FAAFFDACC68BQ36326701-D7F813F7-BB06-415A-B53A-117DADD9C5B9Q36535457-ABC7B35A-AB01-4CF3-98A5-377D7AFFC8B1Q36596894-A09BB39F-79F2-480A-823C-88CA1391EF73Q36647506-56EA453B-05C1-49A4-9305-0E20A4EA0568Q37087438-72445702-48EB-40C9-9765-A9B60B70983FQ37292191-10D79810-22C6-4B21-8DCA-708C230790BBQ38856510-2FA13B13-3C9A-4631-85C7-A72ED62C6C26Q40039972-E41FF58F-02D8-4567-85DC-07FC9A49424CQ42081434-A7177D66-ACFF-4CB5-9176-45FE2C5BF843Q42560566-3FCF9DE7-83FE-415C-AF84-191FB1D4D25B
P2860
Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity.
description
1986 nî lūn-bûn
@nan
1986 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
name
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@ast
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@en
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@nl
type
label
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@ast
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@en
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@nl
prefLabel
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@ast
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@en
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@nl
P1476
Taking mortality in rheumatoid ...... onomic status and comorbidity.
@en
P2093
P304
P407
P577
1986-10-01T00:00:00Z